Hanson Wade 2nd Annual Gene Therapy Summit

June 7-9, 2022 - Boston, MA

With a focus on effectively engaging genetic therapy patients, the 2nd Annual Gene Therapy Summit is a must attend conference for individuals and companies that are serious about building safer and more meaningful gene therapy programs. The summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of patient engagement in genetic therapy and will generate actionable insights through detailed case studies and open discussions.

As gene therapies proliferate and sector investment continues to grow rapidly, engaging with gene therapy patients effectively throughout development has become a priority and a necessity to enhance efficacy.

The conference features experts from companies and institutions including Spark Therapeutics, Ultragenyx, FDA, Global Genes, and CRISPR Therapeutics on key topics to ensure effective creation and implementation of patient-centric gene therapy programs.

To learn more, please visit:

Conference Highlights
  • Hanson Wade 2nd Annual Gene Therapy Summit will be held on June 7-9th, 2022 in Boston, MA.
  • Managing Expectations of Gene Therapy Across Different Stakeholders. Explore strategies to work in conjunction with patient groups across research, development, and commercialization continuum, with insights from Encoded Therapeutics.
  • Incorporating the Latest Regulatory Guidelines on Patient Input. Understand the current regulatory guidelines for integrating patient perspectives and how this applies in the context of genetic therapy development, with insights from the FDA.
  • Designing & Implementing Meaningful Clinical Trials. Build a patient-centered clinical trial protocol, optimize the informed consent process, and develop patient-driven outcome measures, with insights from Solid Biosciences.
  • Tackling Education & Misconceptions in Gene Therapy. Evaluate tools to explain the concept of genomic medicines, including gene editing, create resources and distribute them effectively, with insights from uniQure.

Event Website

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717

You’re already more familiar with brand awareness than you might think. What’s your favorite brand of soft drink, athletic shoe, car, shampoo, streaming content provider? Chances are, you first tried those brands because of their awareness strategies. Whether it was word of mouth or a TV commercial, Facebook post, billboard or coupon, that awareness peaked interest, triggered a purchase reaction, and ideally built customer loyalty.

More About Brand Awareness

5,000+ key syndication outlets across the country. IBN’s extensive system of strategic distribution points maximizes your exposure to an audience of millions, including journalists, investors, day traders, fund managers and a multitude of other interested individuals. Now your press releases, earnings statements, branded articles, shareholder updates, corporate achievements can reach a vast and diverse nationwide audience.

More About InvestorWire

Make sure your message resonates. IBN integrates social media with traditional distribution channels to make sure your message resonates long after initial publication. This innovative model ensures that your news not only crosses the wire, but keeps reverberating via social conversation on Twitter, Facebook, LinkedIn and other social networks.

More About Social MediaIBN Social Media NetworkSocial Media Statistics & FAQs

A unique format with a traditionally different sensory input – hearing.As conferences and events continue to suffer cancellations and greatly reduced attendance, many businesses are wondering how to network with large investor audiences in the new normal. At the same time podcasts have seen a jump in popularity.

More About IBN Podcast Solutions